key: cord-0809604-uwyiplyg
authors: Jiang, Yawen; Ni, Weiyi
title: Impact of supplementary private health insurance on hospitalization and physical examination in China
date: 2020-07-03
journal: nan
DOI: 10.1016/j.chieco.2020.101514
sha: d5e735e85d2dd5485d458483fe4840561a443f98
doc_id: 809604
cord_uid: uwyiplyg

Abstract Private health insurance (PHI) is considered an important supplement to the basic social health insurance schemes in the Chinese healthcare system. However, whether the strategy of engaging PHI as supplementary coverage is effective cannot be determined without knowing the impact of supplementary PHI on healthcare access and utilization, the evidence on which is currently absent in China. Therefore, we aimed to investigate the effects of supplementary PHI on hospitalization and physical examination to provide such evidence in the Chinese setting. We conducted a cross-sectional analysis using data from the 2015 wave of China Health and Retirement Longitudinal Study (CHARLS). Using probit models and bivariate probit models with instrumental variables (IVs), we evaluated the effects of supplementary PHI on the utilization of hospitalization and physical examination. Our analyses provided evidence that supplementary PHI increased the probability of physical examination but decreased that of hospitalization. Our findings suggest that supplementary PHI in China may effectively promote the use of high-value preventive care, thereby reducing subsequent utilization of expensive medical services. The present study provided preliminary evidence that the China healthcare system can benefit from engaging PHI as supplements to SHI.

The proportion of the Chinese population covered by the basic social health insurance (SHI) increased from a moderate rate of 50% to a near-universal rate of 95% during 2005-2011 (1, 2) . These achievements were driven collectively by three major classes of SHI schemes: Urban Employee Basic Medical Insurance (UEBMI), Urban Resident Basic Medical Insurance (URBMI), and New Cooperative Medical Scheme (NCMS) (1, 3) . Among these, UEBMI covers formal employees in urban areas whereas URBMI and NCMS are state-subsidized voluntary programs covering urban and rural residents, respectively (3) . However, the out-of-pocket (OOP) rates associated with SHI, which range from 40% to 70%, remain a major financial challenge to patients with severe illness (1, 4, 5) . More, the state-run medical insurance fund is already running on a tight budget in the context of a continuously aging population (6, 7) , and is estimated to have an accumulated deficit of ￥735.3 billion by 2024 if countermeasures are not implemented (7, 8) . Even more, the superficial coverage and the inequity in benefit designs and reimbursement policies across schemes and regions create a major gap of access and utilization (1, 3, 9) . For example, not only the three schemes differ in the scopes of covered services and conditions, but also the financial generosity of the schemes varies substantially across regions (1, 3) . As such, the government has proposed

The rationale of including PHI as part of the greater healthcare system is that PHI either addresses additional healthcare need by providing expanded access to otherwise uncovered services or reduces OOP burden left uninsured by the SHI policies. The former type is considered supplementary to the SHI schemes whereas the latter is considered complementary (12) . The mainstream PHI policies in China, characterized by reimbursing expensive services such as hospitalization due to critical illness that are not part of SHI benefits, are considered supplementary (7, 8) . The supplementary role of PHI in China was also empirically confirmed by Hou and Zhang who found that the expansion of SHI coverage in Chin did not crowd out PHI purchase, suggesting a lack of overlap in healthcare benefits (13) . However, little is known so far about the actual impact of the current supplementary PHI coverage on healthcare services in China, especially on relatively expensive services such as hospitalization which is what most PHI products in China target at. More, it is difficult to make assumptions about the effects of supplementary PHI in China based on evidence from other regions because the regulation of the PHI market and plans in China are not comparable to the relatively mature PHI markets. For example, discrimination based on pre-existing conditions is not prohibited in the Chinese PHI market (8) . Also, PHI policies usually do not provide realtime reimbursement based on actual service costs (4) . Instead, they pay a pre-determined These aspects of supplementary PHI in China give rise to several theoretical concerns that are relevant to its effects. First, the absence of real-time reimbursement and the lack of affirmative information on the eligibility for reimbursement can make patients cautious about using services because there is a possibility that bills are not reimbursed subsequently. Second, the lump sum payment for a condition may reserve individual motivation to spend frugally because any remaining cash becomes the beneficiary's wealth. Finally, because of the lack of commitment to continuous enrollment by the commercial insurers, beneficiaries may restrain from claiming the benefit if they expect catastrophic medical occurrences in the future.

A noteworthy silver lining of supplementary PHI in China is that it is not uncommon for policies to provide value-adding preventive care such as physical examination (8) , likely motivated by the same cost-minimization rationale as the insurance policies in other countriesto reduce subsequent bills by preventing diseases from happening or gravitating. Consequently, supplementary PHI potentially promotes preventive care use. However, it is also reasonable to expect that insurers only encourage the use of preventive care that will offset the paid amount by the insurers themselves, such as hospitalization due to relatively severe conditions. These complexities put together, the effects of supplementary PHI in China needs to be evidenced empirically to inform the decision-making of the government, the insurers, and possibly even the individual consumers. To insight into such, the present study was conducted to examine the effects of supplementary PHI on the use of inpatient care and preventive care. To our knowledge, the present study represents the first attempt to empirically answer such questions in the setting of China. Our analyses provided J o u r n a l P r e -p r o o f evidence that supplementary PHI in China significantly increased the probability of preventive care but decreased that of inpatient admission. Such results indicated that individuals covered by supplementary PHI experienced improved access to preventive care, which might in turn reduce hospitalization. This might be a result of an on-purpose benefit design from the insurers' end.

The remaining of the paper proceeds as follows. Section 2 gives a review of the literature related to the incentive effects (or lack thereof) of supplementary PHI. Section 3 lays out the theoretical background of insurance effects. Section 4 describes the data and elaborates on the econometric framework used for analyses. Section 5 lists the results of the main analyses and the tests of the identifying assumptions. Section 6 provides a discussion of the results and their implications, following which was a summary of study limitations in section 7. Section 8 concludes the paper.

Whereas the impact of primary insurance on healthcare use has been studied abundantly in numerous countries, such impact of supplementary coverage was investigated less frequently. The literature of the effects of voluntary commercial supplements to the publicly funded Medicare in the US is relatively saturated. Wolfe and Goddeeris (15) examined data from the 1970s and found that Medicare beneficiaries having supplementary PHI had higher expenditures on hospital and physician services.

Also, Coulson et al. (16) found that having Medicare supplements increased the number of prescription fills using 1990 Pennsylvanian data. Consistent with the previous results, J o u r n a l P r e -p r o o f Journal Pre-proof Khandker et al. (17) and Atherly (18) showed strong positive effects of Medicare supplements on total healthcare expenditures. More recently, Keane and Stavrunova (19) provided new evidence that Medicare supplements increased healthcare expenditure.

Focusing on the probability instead of the intensity of healthcare use, Christensen and Shinogle (20) found that Medicare supplements increased the probability of hospitalization using the 1994 National Health Interview Survey data. Their findings were confirmed by Dardanoni and Donni (21) (27) . When compared with nearby New England states, residents of post-reform Massachusetts had higher rates of Pat tests and vaccination (29, 30) . The

Massachusetts health reform was also documented to increase preventive care use that eventually decreased preventable hospitalization (31) . This is particularly of interest to the examination of supplementary PHI in China given the motivation of the latter to offer preventive care. More recently, the Affordable Care Act (ACA) led to changes in two tracks of primary coverage in the US. First, the ACA required all states to expand Medicaid to adults whose income was less than 138 percent of the federal poverty line (FPL). Although the Supreme Court ruled in 2012 that individual states can opt out of the expansion, thirty-one states still enacted the ACA requirement (32) . The ACA also J o u r n a l P r e -p r o o f mandated Medicaid policies in all states to offer a bundle of preventive services at no cost to beneficiaries (33) . Such changes to Medicaid had positive effects on HIV tests but not flu shots and cancer screening (33) . Second, the ACA mandate of providing preventive care without copayment applied not only to public insurance such as Medicaid but also to all primary PHI policies in the US (34) . This has been shown to have increased HPV test among those who were primarily commercially insured (34) . Whereas the findings on the effects of primary coverage are enlightening in that they are consistent with one's expectation of the utility of insurance, they are not necessarily replicable in the analysis of supplemental coverage. To illustrate, the private insurers engage in the objective function of maximizing profit using the benefit design when they provide preventive care, yet it is rational to think that the preventive services mandated by the US government as described in the foregoing studies were devised to maximize either population health or total social welfare. Hence, the spectrum, intensity, and quality of the preventive care provided by primary insurance may be different from that of supplementary PHI.

The effects of supplementary PHI heavily depend on institutional settings.

Especially, the Chinese PHI market is different from the PHI markets in the western countries for the reasons mentioned in the introduction section. In addition, to what extent the basic health insurance addresses healthcare need can affect the behavior of supplementary PHI enrollees (35) . Hence, we aimed to obtain evidence that is specific to the supplementary PHI plans in China.

In general, beneficiaries may increase the use of contracted healthcare services through three mechanisms, namely moral hazard, income transfer effect, and risk reduction effect (36) . Moral hazard, or price effect, means the level of consumption is higher when insurance reduces the costs to the beneficiaries (36, 37) . Two distinct types of moral hazard are ex-ante moral hazard and ex-post moral hazard. The former means beneficiaries refrain from risky health behavior to a lesser extent before realized medical occurrences as a result of feeling financially protected and the latter means they utilize more services given a specific level of health risk (38) . Income transfer effect, or access effect, refers to the mechanism that insurance creates an ex-post transfer of income that makes certain services accessible to the beneficiaries but not so otherwise (36) . It has been argued that the utilization due to income effect is actually an "efficient moral hazard" because the resources are turned into improved health instead of being wasted (37) . The final mechanism relates to the situation that the level of utilization is inversely proportional to financial uncertainty an individual faces, a behavior named risk reduction effect (36) . The three mechanisms are collectively termed insurance effect. The services enveloped into the benefits package are expected to be used more both on the intensive margin and the extensive margin due to the joint force of the three mechanisms.

The profit the insurers make is the difference between the premium they collect and the healthcare expenditure they pay for the beneficiaries. To that end, insurers can optimize benefit design for their interest such that the beneficiaries choose low-cost and high-value preventive care which reduces the overall hospitalization rate. Compared with simply increasing premiums for profit, optimizing benefit design is a more reasonable strategy because it reduces operating costs of insurers that further turns into lower J o u r n a l P r e -p r o o f premiums, thereby becoming more appealing to insurance shoppers. Such a benefit design incentivizes beneficiaries to pick up more ex-post moral hazard concerning preventive care but in effect reduces ex-ante moral hazard related to hospitalization.

However, such information is unknown to researchers a priori. Hence, we follow the general theory of insurance effect and hypothesize that those who had supplementary PHI incurred higher probabilities of both hospitalization and physical examination.

When analyzing the impact of supplementary PHI, it is important to isolate the insurance effect from the selection effect (19, 21) . The selection effect can arise from either adverse selection or advantageous selection. Adverse selection refers to the situation when the high-risk individuals are more likely to purchase insurance, the contrast of which is called advantageous selection (39) . The supplementary PHI markets around the world have been mostly characterized by either advantageous selection or absence of self-selection (39) (40) (41) (42) . Affirmative information on the direction of selfselection can help researchers to determine whether and to what extent the analysis may be affected by omitted variable bias. Without solid evidence on such, we consider it necessary to test and control potential endogeneity in the present analysis.

The present study was a cross-sectional analysis using data from the 2015 wave of the China Health and Retirement Longitudinal Study (CHARLS). CHARLS is an aging survey of 45 years and older Chinese and their spouses that used a multistage probability J o u r n a l P r e -p r o o f sampling to allow nationally representative estimates (5, 43, 44) . The data from the 2015 wave included 20,284 respondents with positive cross-sectional weights. The types of information that the survey collected were 1) socioeconomic information including age, sex, education, residence (rural or urban), assets, income, working status, pension, and health insurance status; 2) health information including self-reported general health, thirteen physician-diagnosed chronic conditions, memory problem, past-year hospitalization, past-month outpatient visit, and the time of last physical examination if any (past-year preventive care use can be created using timestamp); and 3) behavioral questions including smoking status and alcohol ingestion frequency. More information on CHARLS has been described elsewhere (43, 45) . To investigate the properties of PHI as supplementary insurance, we used the subsample that had SHI coverage in this analysis.

We examined the effects of supplementary PHI on both hospitalization and physical examination. The latter was analyzed as a proxy for preventive care. We illustrated our analysis using hospitalization, but the analysis of physical examination 

where Pr() is the probability of the event in the parentheses. To examine the effect of supplementary PHI on the probability of hospitalization, we first conducted a probit regression that takes the form:

where is the probit link function. In this multivariate probit regression,

represented 1) basic demographic information including age, sex and whether living in a rural area; 2) health condition information including the self-reported general health variable and indicators of thirteen chronic diseases; 3) socioeconomic information including total wealth (in ¥1,000), annual income (in ¥1,000) and education level (an indicator for high school or above); 4) risky health behavior including smoking and alcohol ingestion frequency (daily or more often); and 5) SHI types. The self-reported general health question had five categories (1 excellent, 2 very good, 3 good, 4 fair, 5 poor). When conducting regressions, we created a general health indicator (GHI) variable for fair or better health status because the median category was fair. Two variables used to denote the SHI types were an indicator for UEBMI and an indicator for NCMS.

Having SHI types other than UEBMI and NCMS was the baseline category. It should be noted that the percentages of all SHI categories added up to a bit over 100% but not exactly 100% since the survey itself did not force respondents to check only one option.

The coefficients of the probit regression cannot be interpreted straightforwardly. Hence, J o u r n a l P r e -p r o o f we present the marginal effects of the regressors on the probability of hospitalization in the results section which were calculated as

where is the jth parameter of which the marginal effect was evaluated and is the normal density function. Marginal effects were only applicable to continuous variables.

For indicator variables, the incremental effects were evaluated. Using PHI as an example, the incremental effect was evaluated as

The standard errors were estimated using the delta method (46) .

The identifying assumption of the probit regression was that PHI was uncorrelated with . However, in equation (2) (3) and (4).

The identifying assumptions of the bivariate probit model were that the IVs were strong predictors of PHI and were exogenous to the outcomes. To test the non-weakness of the IVs, we conducted a side-track linear probability model of PHI on the IVs. The

Staiger-Stock rule of thumb is that the F-statistic of regressing the endogenous variable on non-weak IVs using a linear model should be greater than 10 (54). In addition, we conducted a 2SLS regression alongside the BVP model. Although the effect estimates using 2SLS were more vulnerable to bias than the BVP estimates, we still relied on the 2SLS for two tests to verify the identifying assumptions since there are no equivalent tests in non-linear IV models. First, a Cragg-Donald Wald F statistic was obtained for a weak identification test following the 2SLS. The rationale of this test is that the IV estimate is always biased but weak IVs generate bias that is as great as or even greater than an ordinary least squares (OLS) estimate, and the Cragg-Donald Wald F statistic needs to be greater than a certain critical value to limit the bias of the IV estimate within a level that is acceptable (55) . Second, the over-identification test was used to examine J o u r n a l P r e -p r o o f the exogeneity of the IVs. Rejection of the null hypothesis of the over-identification test means at least one IV was not exogenous (56) .

All analyses incorporated respondent sampling weights and were carried out using Stata (version 15; Stata Corp, College Station, TX, USA).

We The results of the analyses related to the non-weakness of IVs are presented in Table 3 . The first-stage F-statistic was 23.28, which was greater than the Staiger-Stock The results of PHI choice equations in the BVPs (the counterparts of first-stage equations in 2SLS) are also presented. Table 4 contains the choice equation estimates from the BVPs of both outcomes. There were two sets of estimates because the sample sizes of the two analyses were slightly different due to missing values. According to the results in Table 4 , both IVs significantly predicted PHI coverage. Also, the estimates across the two BVP models were close to each other although there was nuance in magnitudes. The category of social health insurance other than UEBMI and NCMS was left out in regressions.

Using IV methods to account for endogeneity in the analysis of CHARLS data, To unleash the potential of supplementary PHI, additional policies should be implemented to reinvigorate the PHI market.

The significance of leveraging PHI to encourage preventive care uptake and to reduce hospitalization may even go beyond access and state budget-sharing motivation. outbreak (61) . Based on the findings of the present study, PHI could be an option to effectively promote high-value preventive care such as vaccines that are not part of the publicly funded immunization programs. Because private insurers are more flexible than social insurance agencies to decide which organizations and professionals to contract and what benefits to provide in China, they can more swiftly adjust their products to include such high-value care to meet evolving market demand (13) .

The present analysis relied on IVs to identify the effects of supplementary PHI. Omitted variable bias due to self-selection is a major threat to the validity of the analysis of insurance effect, whereas reverse causality is another common source of endogeneity.

The naïve analyses of both hospitalization and physical examination were affected by endogeneity as shown by the IV analyses. Therefore, the analyses without adjusting for endogeneity generated unreliable estimates. Specifically, the naïve analysis of hospitalization did not identify any significant effect associated with supplementary PHI whereas the IV analysis retrieved the risk-reduction effect. Had the IV analyses not been conducted, the analysis would have missed such a risk-reduction effect.

In addition to the main analyses using probit models and bivariate probit models with IVs, we also conducted several post hoc analyses using alternative specifications as robustness checks. First, we re-categorized self-reported general health into two indicators for excellent or very good and good or fair, respectively. The two indicators were then adjusted for in the multivariate regressions in lieu of the original GHI indicator.

In these alternative specifications, the estimates of the marginal effects of PHI changed the concern of omitted variable bias might also be raised by the regional heterogeneity of 

Several caveats must be noted for the inference of the findings.

Although we used multivariate regressions with a long list of adjusted variables and conducted IV analyses, we could not rule out the possibility of residual confounding.

Addressing endogeneity is challenging in a cross-sectional study using retrospective data.

On top of these, it should be noted that the IVs we chose were not guaranteed to be fully exogenous even though the weak instrument tests and the over-identification tests suggested good IV properties overall. In particular, the over-identification tests were initially used to test IV orthogonality in linear model specifications. (56) . To further examine the orthogonality of the IVs, we conducted a falsification test using a past-month outpatient visit indicator as a negative control, which was an outcome that the IV estimates were supposed to suggest no PHI effect. This is because PHI usually targets expensive services such as hospitalization instead of outpatients which are much less expensive and are relatively sufficiently addressed by basic SHI schemes. The estimated incremental effect of PHI on the probability of past-month outpatient visits was 0.417 (SE: 0.335, p=0.213). Therefore, the results of the falsification test also endorsed the validity of the IVs.

In addition, the sample size of this study is relatively limited, which could result in underpowered analysis in the probit regression of hospitalization in which PHI appeared to be statistically insignificant. This issue is primarily caused by the low uptake rate of PHI among the Chinese population. An analysis of PHI in a relatively mature market would allow the inclusion of more PHI-covered individuals. However, the necessity of an analysis on the impact of PHI may accordingly diminish when PHI has been well-established and accepted.

More, some of the variables were based on self-report and might be subject to recall bias. Although electronic data provided by insurers could be relatively more reliable research resources, such data are not currently available in China to our knowledge. Notwithstanding its commonality in survey data, the impact of recall bias on the estimates of interest in the present study should not be overstated. Report error is not very likely to have a strong, if any, association with PHI. Although more likely than the exposure variable, the outcome variables still had relatively small chances of major misreport because of their "yes or no" response type and their salient nature (63) . In another regard, recall bias causes biased estimates of PHI effects if individuals in an exposure group systematically remembered things differently than the other group, which is not a plausible scenario in the case of the present study. Thus, recall bias should not be a major threat to the validity of the present study. As an empirical check of these assumptions, we investigated how surrogates of recall bias might associate with PHI and whether these surrogates could impact PHI effect estimates. Specifically, CHARLS together, report errors of specific items could not be ruled out but did not cause major impact on PHI effect estimates.

Even more, the granularity of healthcare utilization information in the survey data was limited. For example, we were only able to use physical examination as a proxy for preventive care. Hence, we could not investigate the effects of supplementary PHI on other high-value procedures or services that represent improved access. Finally, we did not specifically establish the impact of preventive care on hospitalization. This is a complicated yet important analysis in its own right and poses equally challenging endogeneity issues as supplementary PHI. We relied on established evidence in the literature for the connection between preventive care and hospitalization (27, 31) with the recognition of a potential lack of generalizability of such evidence.

J o u r n a l P r e -p r o o f

Supplementary PHI in China may be effective to improve access to high-value preventive care and to reduce the expensive medical occurrence. Overall, it increases efficiency in the healthcare sector and has the potential to address additional preventive care need. Although future studies on ascertaining the effects of supplementary PHI on accessing expensive services and reducing out-of-pocket financial burden are required to completely understand the utility of supplementary PHI, the present study provided preliminary evidence that the China healthcare system can benefit from engaging PHI as supplements to SHI.

Universal health insurance coverage for 1.3 billion people: What accounts for China's success? Health policy

Health Insurance In China: After Declining In The 1990s, Coverage Rates Rebounded To Near-Universal Levels By

China's health reform update

Oppurtunities Open Up in Chinese Private Health Insurance Beijing, China: Boston Consulting Group

Health insurance and health care among the mid-aged and older Chinese: Evidence from the national baseline survey of CHARLS. Health economics

Private health insurance in China: Finding the winning formula: McKinsey & Company

The rise of private health insurance in China: Ernst & Young Global Limited

While paper on China commerical health insurance: Ernst & Young Global Limited

National health insurance development in China from 2004 to 2011: coverage versus benefits

The expansion of public health insurance and the demand for private health insurance in rural China

Notice of the Ministry of Finance, the State Administration of Taxation and the China Insurance Regulatory Commission on Promoting Nationwide Pilot Policies for Individual Income Tax on Commercial Health Insurance

Testing for Asymmetric Information in Private Health Insurance

The effects of public health insurance expansion on private health insurance in urban China

Global marketplace for private Health Insurance: strength in numbers

Adverse selection, moral hazard, and wealth effects in the Medigap insurance market

Estimating the moral-hazard effect of supplemental medical insurance in the demand for prescription drugs by the elderly

Medicare spending by beneficiaries with various types of supplemental insurance

The effect of Medicare supplemental insurance on Medicare expenditures

Adverse selection, moral hazard and the demand for Medigap insurance

Effects of supplemental coverage on use of services by Medicare enrollees

Incentive and selection effects of Medigap insurance on inpatient care

Access to physician services: does supplemental insurance matter? Evidence from France. Health economics

Supplemental health insurance and equality of access in Belgium

Effects of supplementary private health insurance on physician visits in Korea

Menezes-Filho N, Politi R. Estimating the Causal Effects of Supplemental Health Coverage in Brazil: evidence from regression discontinuity design

Health Insurance Effects on Preventive Care and Health : A Methodologic Review

THE OREGON HEALTH INSURANCE EXPERIMENT: EVIDENCE FROM THE FIRST YEAR

The Effect of the Massachusetts Reform on Health Care Utilization. INQUIRY: The Journal of Health Care Organization, Provision, and Financing

The Impact of Near-Universal Insurance Coverage on Breast and Cervical Cancer Screening: Evidence from Massachusetts

The impact of health care reform on hospital and preventive care: Evidence from Massachusetts

Understanding The Relationship Between Medicaid Expansions And Hospital Closures

The Impact of Health Insurance on Preventive Care and Health Behaviors: Evidence from the First Two Years of the ACA Medicaid Expansions

ACA Provisions Associated With Increase In Percentage Of Young Adult Women Initiating And Completing The HPV Vaccine

Basic versus supplementary health insurance: access to care and the role of cost effectiveness

The impact of having supplementary private health insurance on the uses of specialists

Basic Versus Supplementary Health Insurance: Moral Hazard and Adverse Selection

A Note on Health Insurance under Ex Post Moral Hazard

Sources of advantageous selection: Evidence from the Medigap insurance market

Preference heterogeneity and selection in private health insurance: The case of Australia

The effect of health on acute care supplemental insurance ownership: an empirical analysis

Voluntary private health insurance among the over 50s in Europe. Health economics

Cohort profile: The China health and retirement longitudinal study (CHARLS)

Associations between long-term exposure to ambient particulate air pollution and type 2 diabetes prevalence, blood glucose and glycosylated hemoglobin levels in China

Harmonized CHARLS Documentation

A computational trick for delta-method standard errors

Econometric analysis: Pearson Education India

Econometric analysis of cross section and panel data

Advertising and Risk Selection in Health Insurance Markets

Consumption Externality and Equilibrium Underinsurance

Estimating probit models with self-selected treatments

Endogeneity in probit response models

A practical comparison of the bivariate probit and linear IV estimators

Instrumental variables regression with weak instruments

Enhanced routines for instrumental variables/GMM estimation and testing

Microeconometrics using STATA

Value Based Cost Sharing Meets the Theory of Moral Hazard: Medical Effectiveness in Insurance Benefits Design

Value-Based Insurance Design Improves Medication Adherence Without An Increase In Total Health Care Spending

Impact of a value-based formulary in three chronic disease cohorts

Prospective cohort study on the effectiveness of influenza and pneumococcal vaccines in preventing pneumonia development and hospitalization

Wuhan is running low on food, hospitals are overflowing, and foreigners are being evacuated as panic sets in after a week under coronavirus lockdown 2020

Using heteroscedasticity to identify and estimate mismeasured and endogenous regressor models

Forgetting to remember or remembering to forget: A study of the recall period length in health care survey questions

The multi-level health insurance system in China engages private health insurance (PHI) as an important supplement to the social health insurance schemes.  However, evidence on the impact of supplementary PHI on healthcare access and utilization is currently absent in China.

The present study used instrumental variable analyses to provide evidence that supplementary PHI increased the probability of physical examination but decreased that of hospitalization.

The results suggest that supplementary PHI may promote the use of preventive care, thereby reducing subsequent utilization of expensive medical services.